Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
An announcement from Guangzhou Baiyunshan Pharmaceutical Holdings Company ( (HK:0874) ) is now available.
Guangzhou Baiyunshan Pharmaceutical Holdings Company announced the progress of a connected transaction involving a capital increase in its subsidiary, Baiyunshan Biological. The agreement, which includes several investment funds, maintains the company’s 50% equity interest in Baiyunshan Biological, ensuring its continued consolidation into the company’s financial statements.
The most recent analyst rating on (HK:0874) stock is a Hold with a HK$21.70 price target. To see the full list of analyst forecasts on Guangzhou Baiyunshan Pharmaceutical Holdings Company stock, see the HK:0874 Stock Forecast page.
More about Guangzhou Baiyunshan Pharmaceutical Holdings Company
Guangzhou Baiyunshan Pharmaceutical Holdings Company is a joint stock company with limited liability established in the People’s Republic of China. It operates in the pharmaceutical industry, focusing on the production and distribution of pharmaceutical products.
YTD Price Performance: -2.03%
Average Trading Volume: 1,116,875
Technical Sentiment Signal: Sell
Current Market Cap: HK$44.33B
See more data about 0874 stock on TipRanks’ Stock Analysis page.